| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.0M | — |
| R&D Expense | $29.3M | -44.8% |
| SG&A Expense | $19.2M | +19.8% |
| Operating Income | -$22.5M | +67.5% |
| Pre-tax Income | -$15.4M | +75.1% |
| Income Tax | $223K | +85.8% |
| Net Income | -$15.6M | +74.8% |
| EPS (Basic) | -$0.28 | +75.2% |
| EPS (Diluted) | -$0.28 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $78.2M | -26.0% |
| Short-term Investments | $15.5M | +22.4% |
| Accounts Receivable | $789K | — |
| Current Assets | $97.0M | -20.9% |
| Total Assets | $101.3M | -20.5% |
| Current Liabilities | $8.5M | -66.5% |
| Total Liabilities | $9.1M | -64.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.6M | +50.5% |
| Capital Expenditures | $750K | +825.9% |
| Investing Cash Flow | -$3.5M | -104.6% |
| Financing Cash Flow | $227K | +404.4% |
| Free Cash Flow | -$24.4M | +49.1% |
| +75.2% |
| Stockholders' Equity |
| $92.2M |
| -9.2% |